1. Home/
  2. Compounds/
  3. tanespimycin:bortezomib (250:1 mol/mol)

tanespimycin:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tanespimycin:bortezomib (250:1 mol/mol)
PharmacoGx tanespimycin:bortezomib (250:1 mol/mol)

Cell lines tested with tanespimycin:bortezomib (250:1 mol/mol)

797 cell lines have been tested with this compound, using data from 1 dataset(s).
A549 lung CTRPv23
DU-145 prostate CTRPv22
AsPC-1 pancreas CTRPv22
NCI-H1869 lung CTRPv22
CCF-STTG1 central nervous system CTRPv22
OAW-28 ovary CTRPv22
HeLa cervix CTRPv22
LOXIMVI haematopoietic and lymphoid tissue CTRPv22
NCI-H520 lung CTRPv22
IGROV-1 ovary CTRPv22
Download CSV

Tissues tested with tanespimycin:bortezomib (250:1 mol/mol)

25 tissues have been tested with this compound, using data from 1 dataset(s).
lungCTRPv2142
haematopoietic and lymphoid tissueCTRPv2135
N/ACTRPv247
central nervous systemCTRPv245
skinCTRPv244
pancreasCTRPv240
large intestineCTRPv239
ovaryCTRPv238
breastCTRPv237
stomachCTRPv232
Download CSV
Download Data as CSV

Top molecular features associated with response to tanespimycin:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA AAR2 CTRPv2 AAC -0.043 0.3
mRNA AARD CTRPv2 AAC 0.051 0.2
mRNA AARS CTRPv2 AAC -0.023 0.5
mRNA AARS2 CTRPv2 AAC -0.018 0.7
mRNA AARSD1 CTRPv2 AAC 0.018 0.6
mRNA AASDH CTRPv2 AAC -0.0048 0.9
mRNA AASDHPPT CTRPv2 AAC 0.0023 1
mRNA AASS CTRPv2 AAC -0.014 0.7
mRNA AATF CTRPv2 AAC 0.013 0.7
mRNA AATK CTRPv2 AAC 0.04 0.3
Download CSV